Billy R Hammond1, Laura M Fletcher1, Franz Roos2, Jonas Wittwer2, Wolfgang Schalch2. 1. Vision Sciences and Human Biofactors Laboratories, Department of Psychology, University of Georgia, Athens, Georgia, United States. 2. DSM Nutritional Products Ltd., Wurmisweg, Kaiseraugst, Switzerland.
Abstract
PURPOSE: Past studies have shown that higher macular pigment optical density (MPOD) and lutein (L) and zeaxanthin (Z) supplementation are related to improvements in glare disability, photostress recovery, and chromatic contrast. This study assessed those links using a randomized, double-blind, placebo-controlled design. METHODS: The visual effects of 1 year of supplementing L (10 mg/d) and Z (2 mg/d) were investigated. One hundred fifteen young, healthy subjects were recruited and randomized into the study (58 received placebo, 57 L+Z). Several dependent measures were collected at baseline and then once every 3 months: serum L and Z measured by HPLC chromatography; MPOD measured using customized heterochromatic flicker photometry; photostress recovery assessed by measuring the time needed to recover visual acquisition of a grating target after 30 seconds of an intense xenon white flash exposure; glare disability evaluated as the energy in a surrounding annulus necessary to veil a central grating target; and chromatic contrast assessed by measuring thresholds for a yellow grating target superposed on a 460-nm background. RESULTS:Macular pigment optical density increased significantly versus placebo at all eccentricities (10, 30, 60, and 105 minutes from the center of the macula). Serum L and Z also increased significantly by the first follow-up visit (at 3 months), and remained elevated throughout the intervention period of 1 year. Chromatic contrast and photostress recovery time improved significantly versus placebo. Glare disability was correlated with macular pigment density throughout the study period but did not increase significantly in the treated group. CONCLUSIONS: Daily supplementation with L+Z resulted in significant increase in serum levels and MPOD and improvements in chromatic contrast and recovery from photostress. These results are consistent with past studies showing that increasing MPOD leads to improved visual performance. (ClinicalTrials.gov number, NCT00909090.). Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
RCT Entities:
PURPOSE: Past studies have shown that higher macular pigment optical density (MPOD) and lutein (L) and zeaxanthin (Z) supplementation are related to improvements in glare disability, photostress recovery, and chromatic contrast. This study assessed those links using a randomized, double-blind, placebo-controlled design. METHODS: The visual effects of 1 year of supplementing L (10 mg/d) and Z (2 mg/d) were investigated. One hundred fifteen young, healthy subjects were recruited and randomized into the study (58 received placebo, 57 L+Z). Several dependent measures were collected at baseline and then once every 3 months: serum L and Z measured by HPLC chromatography; MPOD measured using customized heterochromatic flicker photometry; photostress recovery assessed by measuring the time needed to recover visual acquisition of a grating target after 30 seconds of an intense xenon white flash exposure; glare disability evaluated as the energy in a surrounding annulus necessary to veil a central grating target; and chromatic contrast assessed by measuring thresholds for a yellow grating target superposed on a 460-nm background. RESULTS: Macular pigment optical density increased significantly versus placebo at all eccentricities (10, 30, 60, and 105 minutes from the center of the macula). Serum L and Z also increased significantly by the first follow-up visit (at 3 months), and remained elevated throughout the intervention period of 1 year. Chromatic contrast and photostress recovery time improved significantly versus placebo. Glare disability was correlated with macular pigment density throughout the study period but did not increase significantly in the treated group. CONCLUSIONS: Daily supplementation with L+Z resulted in significant increase in serum levels and MPOD and improvements in chromatic contrast and recovery from photostress. These results are consistent with past studies showing that increasing MPOD leads to improved visual performance. (ClinicalTrials.gov number, NCT00909090.). Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Anne M Walk; Naiman A Khan; Sasha M Barnett; Lauren B Raine; Arthur F Kramer; Neal J Cohen; Christopher J Moulton; Lisa M Renzi-Hammond; Billy R Hammond; Charles H Hillman Journal: Int J Psychophysiol Date: 2017-05-19 Impact factor: 2.997
Authors: Binxing Li; Preejith P Vachali; Zhengqing Shen; Aruna Gorusupudi; Kelly Nelson; Brian M Besch; Alexis Bartschi; Simone Longo; Ty Mattinson; Saeed Shihab; Nikolay E Polyakov; Lyubov P Suntsova; Alexander V Dushkin; Paul S Bernstein Journal: Exp Eye Res Date: 2017-03-09 Impact factor: 3.467
Authors: Anna V Zarubina; Carrie E Huisingh; Mark E Clark; Kenneth R Sloan; Gerald McGwin; Jason N Crosson; Christine A Curcio; Cynthia Owsley Journal: Curr Eye Res Date: 2018-05-01 Impact factor: 2.424
Authors: Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan Journal: Prog Retin Eye Res Date: 2015-11-02 Impact factor: 21.198
Authors: Binxing Li; Gregory T Rognon; Ty Mattinson; Preejith P Vachali; Aruna Gorusupudi; Fu-Yen Chang; Arunkumar Ranganathan; Kelly Nelson; Evan W George; Jeanne M Frederick; Paul S Bernstein Journal: Arch Biochem Biophys Date: 2018-05-06 Impact factor: 4.013
Authors: Regan L Bailey; Tieraona Low Dog; Abbie E Smith-Ryan; Sai Krupa Das; Fiona C Baker; Zeynep Madak-Erdogan; Billy R Hammond; Howard D Sesso; Alex Eapen; Susan H Mitmesser; Andrea Wong; Haiuyen Nguyen Journal: J Nutr Date: 2022-07-06 Impact factor: 4.687